Consolidated Balance Sheets - USD ($) $ in Millions	Mar. 31, 2023	Mar. 31, 2022
ASSETS
Cash and cash equivalents	$ 6,398	$ 7,670
Restricted cash and cash equivalents	2,090	2,065
Investments in marketable securities	5,037	4,953
Finance receivables, net of allowance for credit losses of $1,489 and $1,246, respectively	90,280	82,432
Investments in operating leases, net	29,869	35,455
Other assets	3,921	2,466
Total assets	137,595	135,041
LIABILITIES AND SHAREHOLDER'S EQUITY
Debt	111,685	109,152
Deferred income taxes	3,727	1,564
Other liabilities	5,674	6,224
Total liabilities	121,086	116,940
Commitments and contingencies (Refer to Note 9)
Shareholder's equity:
Capital stock, no par value (100,000 shares authorized; 91,500 issued and outstanding) at March 31, 2023 and 2022	915	915
Additional paid-in capital	2	2
Accumulated other comprehensive loss	(57)	(21)
Retained earnings	15,649	17,205
Total shareholder's equity	16,509	18,101
Total liabilities and shareholder's equity	$ 137,595	$ 135,041